ClinicalTrials.gg
RecruitingNCT07606079Updated May 26, 2026

Comparison of Different Scales for The Prediction of Difficult Airway

An observational study in Modified Thyromental Distance, sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-26.

Sponsored by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
850
Ages
18 Years and older
Sex
All
01

Study summary

Although many tests exist for predicting a difficult airway, the search for a test with substantially higher specificity and sensitivity is still ongoing. The aim of this study is to evaluate the specificity and sensitivity of modified thyromental distance and modified sternomental distance measurements, scaled according to the patient's own three-finger breadth, in predicting difficult laryngoscopy and difficult tracheal intubation.

02

Conditions studied

  • Modified Thyromental Distance

Keywords

  • Difficult airway
  • Modified thyromental distance
03

In context

Lead sponsor

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization is the lead sponsor of 87 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 18 years and older.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years and older who agreed to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients who refused to participate in the study
  • Patients with limited neck mobility
  • Patients whose mouth opening is smaller than the width of their own three fingers
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
850 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Sensitivity and specificity of patient-specific modified thyromental distance for predicting difficult intubation

    Time frame: During the 6-month study period, for each patient, the Cormack-Lehane score will be recorded when direct laryngoscopy is performed after induction of anesthesia in the perioperative period.

07

Study locations

1 of 1 sites recruiting
  • Prof. Dr. Cemil Tascioglu City Hospital
    Istanbul, 34384, Turkey (Türkiye)
    Recruiting
    • Burak Çağrı Çevik · Contactburakcagricevik@gmail.com · +905302651095
    • Serap Karacalar, Professor Doctor · Principal investigator
    • Burak Ç Çevik, Resident Doctor · Sub investigator
    • Gamze Demir, Resident Doctor · Sub investigator
    • Betül Gözübüyük, Resident Doctor · Sub investigator
    • Ece Özcan, Resident Doctor · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Jun 2026, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 13, 2026
First posted
May 26, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jun 30, 2026
Last update
May 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07606079
Lead sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Responsible party
SERAP KARACALAR (Professor, Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization) — Principal investigator
First posted
May 26, 2026
Start date
Jan 1, 2026
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
May 26, 2026

Study contacts

Burak Ç Çevik, Resident Doctor
Contact
burakcagricevik@gmail.com
+905302651095
Gamze Demir, Resident Doctor
Contact
gmzdmr1453@gmail.com
+905522343146
Serap Karacalar, Professor Doctor
principal investigator · SBU Prof. Dr. Cemil Tascioglu City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion